Luis E Cuevas
Overview
Explore the profile of Luis E Cuevas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
143
Citations
3062
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Savage H, Rickman H, Burke R, Odland M, Savio M, Ringwald B, et al.
Lancet Microbe
. 2023 Sep;
4(10):e811-e821.
PMID: 37714173
Background: Pulmonary tuberculosis due to Mycobacterium tuberculosis can be challenging to diagnose when sputum samples cannot be obtained, which is especially problematic in children and older people. We systematically appraised...
2.
Iem V, Bimba J, Santos V, Dominguez J, Creswell J, Somphavong S, et al.
BMC Infect Dis
. 2023 May;
23(1):341.
PMID: 37217868
Background: The World Health Organization (WHO) recommends the diagnosis of tuberculosis (TB) using molecular tests, such as Xpert MTB/RIF (MTB/RIF) or Xpert Ultra (Ultra). These tests are expensive and resource-consuming,...
3.
Borges L, Guimaraes A, Fonseca D, Freire P, Barreto I, Souza D, et al.
Heliyon
. 2023 Apr;
9(3):e14398.
PMID: 37016723
[This corrects the article DOI: 10.1016/j.heliyon.2022.e11368.].
4.
Borges L, Guimaraes A, Fonseca D, Freire P, Barreto I, Souza D, et al.
Heliyon
. 2022 Nov;
8(11):e11368.
PMID: 36349284
Brazil experienced one of the most prolonged periods of school closures, and reopening could have exposed students to high rates of SARS-CoV-2 infection. However, the infection status of students and...
5.
Iem V, Xangsayarath P, Chittamany P, Suthepmany S, Siphanthong S, Paboriboune P, et al.
PLoS One
. 2022 Sep;
17(9):e0275294.
PMID: 36173954
The COVID-19 pandemic created the need for large-scale testing of populations. However, most laboratories do not have sufficient testing capacity for mass screening. We evaluated pooled testing of samples, as...
6.
Pembi E, Omoleke S, Paul H, Augustine T, Cuevas L
J Infect
. 2022 Sep;
85(6):702-769.
PMID: 36116572
No abstract available.
7.
Savage H, Finch L, Body R, Watkins R, Hayward G, Cook E, et al.
PLoS One
. 2022 Jun;
17(6):e0270715.
PMID: 35771760
Background: Rapid diagnostic tests (RDTs) developed for point of care detection of SARS-CoV-2 antigen are recommended by WHO to use trained health care workers to collect samples. We hypothesised that...
8.
Bigio J, Vasquez N, Huria L, Pande T, Creswell J, Ananthakrishnan R, et al.
BMJ Glob Health
. 2022 Apr;
7(4).
PMID: 35440442
No abstract available.
9.
Edwards T, Heinz E, van Aartsen J, Howard A, Roberts P, Corless C, et al.
Microb Genom
. 2022 Apr;
8(4).
PMID: 35404783
Resistance to piperacillin/tazobactam (TZP) in has predominantly been associated with mechanisms that confer resistance to third-generation cephalosporins. Recent reports have identified strains with phenotypic resistance to piperacillin/tazobactam but susceptibility to...
10.
Kay G, Owen S, Giorgi E, Clark D, Williams C, Menzies S, et al.
Sci Rep
. 2022 Mar;
12(1):3351.
PMID: 35233014
Severe acute respiratory coronavirus 2 (SARS-CoV-2) has spread globally since its emergence in 2019. Most SARS-CoV-2 infections generate immune responses leading to rising levels of immunoglobulins (Ig) M, A and...